These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2454197)

  • 1. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
    Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
    Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP; Tsou K
    Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
    Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
    Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
    Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP; Tsou K
    J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
    Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A
    Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of GABA and substance P on metabolism of striatal dopamine following experimental cerebral ischemia].
    Li QY
    Zhonghua Yi Xue Za Zhi; 1993 Nov; 73(11):677-9, 702. PubMed ID: 7510213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intranigral injection of taurine and GABA on striatal dopamine release monitored voltammetrically in the unanaesthetized rat.
    O'Neill RD
    Brain Res; 1986 Sep; 382(1):28-32. PubMed ID: 3768678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Aminobutyric acid infusion in substantia nigra pars reticulata in rats inhibits ascorbate release in ipsilateral striatum.
    Christensen JC; Wang Z; Rebec GV
    Neurosci Lett; 2000 Feb; 280(3):191-4. PubMed ID: 10675793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.